Pursuant to Regulation 30 and 32 of SEBI Listing Regulations, Sai Life Sciences informed that it enclosed the report of Monitoring Agency for the quarter ended 30th September 2026, issued by CRISIL Ratings Limited in relation to the utilisation of proceeds raised through the Company's Initial Public Offer (IPO).